The S100 family is a prognostic biomarker and correlated with immune cell infiltration in pan-cancer
2024 · Discover Oncology · 9 citations
https://doi.org/10.1007/s12672-024-00945-x
Z
Zihong Cai
Nanfang Hospital(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
43
Papers
199
Citations
8
h-index
5
i10-index
Zihong Cai is an academic researcher from Nanfang Hospital. The author has contributed to research in topics: Acute Lymphoblastic Leukemia research & Childhood Cancer Survivors' Quality of Life & Chronic Myeloid Leukemia Treatments. The author has an h-index of 8, co-authored 37 publications.
ORCID: 0009-0005-4848-9508Papers by this author
worksInterleukin-21 engineering enhances CD19-specific CAR-NK cell activity against B-cell lymphoma via enriched metabolic pathways
2025 · Experimental Hematology and Oncology · 5 citations
https://doi.org/10.1186/s40164-025-00639-2
Application Value of Endoscopic Ultrasonography in Diagnosis and Treatment of Inflammatory Bowel Disease
2024 · Digestive Diseases and Sciences · 1 citations
https://doi.org/10.1007/s10620-024-08751-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat